Search results
Pfizer confirms COVID pill's results, potency versus omicron
AOL· 2 weeks agoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron ...
New Covid variant 'FLiRT' capable of evading the immune system: Experts
Investing.com· 3 days agoFLiRT, which belongs to Omicron's JN.1 lineage, is rapidly replacing the previous variant, Eris, in...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 6 days agoS. Wesley Long, who directs the testing lab at Houston Methodist Hospital — and over the past week...
A Man Had Covid For 613 Straight Days—and Created a Whole New Mutation
Popular Mechanics via AOL· 2 weeks agoA new case study of a 72-year-old man from the Netherlands...how immunocompromised people can give...
A Dutch man with lymphoma and other blood disorders was infected with the COVID-causing virus for...
Scientific American· 7 days agoIn the following 612 days, during which time he was in and out of the hospital, the man continued to...
Study: HHS's COVID vaccine campaign saved $732 billion in averted infections, costs
Center for Infectious Disease Research and Policy· 17 hours agoThe study was published yesterday in the American Journal of Preventive...
COVID-19 hospitalizations hit record low, the CDC says
ABC13 Houston· 1 week agoThere were 5,615 COVID hospitalizations in the most recent week data that is available. In...
High-risk patients with COVID symptoms should use PCR rather than rapid tests, study suggests
Center for Infectious Disease Research and Policy· 6 days agoThe study, published in Morbidity and Mortality Weekly Report, also showed a RAT sensitivity of 80%...
American Journal of Preventive Medicine Study Finds COVID-19 Vaccination Public Education Campaign...
Sierra Sun Times· 24 hours agoThe U.S. Department of Health and Human Services’ (HHS) COVID-19 Vaccination Public Education...
University of Minnesota strengthens case to treat COVID-19 with metformin, not ivermectin
Star Tribune (Minneapolis) via Yahoo News· 6 days agoPatients with COVID-19 had lower viral loads if treated with metformin, according to new University of Minnesota research that argues for broader use of the cheap anti-diabetes drug